. Author manuscript; available in PMC: 2015 Apr 1.

Published in final edited form as: Arthritis Rheumatol. 2014 Mar 28;66(4):990–999. doi: 10.1002/art.38319

Table II.

μCT Indices from Mature Mice administered Ig or CTLA4-Ig for 6 months

Mature Mice	Indices	Ig	CTLA4-Ig	% Change	P ≤
L3 Vertebrae	BV/TV [%]:	11.74 ± 1.26	13.31 ± 1.85	+13.4	0.0730
	Tb.Th. [mm]:	0.0508 ± 0.0034	0.0492 ± 0.0045	−3.2	0.4324
	Tb.N. [/mm]:	2.72 ± 0.12	2.94 ± 0.19	+8.2	*0.0154
	Tb. Sp. [mm]:	0.3658 ± 0.0170	0.3409 ± 0.0222	−6.8	*0.0292
Femur	BV/TV [%]:	0.82 ± 0.48	1.11 ± 0.67	+36.1	0.3275
	Tb.Th. [mm]:	0.0506 ± 0.0111	0.0406 ± 0.0128	−19.7	0.1181
	Tb.N. [/mm]:	2.35 ± 0.14	2.39 ± 0.21	+1.7	0.6608
	Tb. Sp. [mm]:	0.4197 ± 0.1075	0.4463 ± 0.0353	+6.3	0.5171
	Co. Ar. [mm²]:	0.7716 ± 0.0314	0.7940 ± 0.0419	+2.9	0.2464
	Co. Th. [mm]:	0.1774 ± 0.0085	0.1769 ± 0.0135	−0.3	0.9306

Mean ± SD; Mature Mice: n=8 Ig and 7 CTLA4-Ig mice/group. Exact P values are indicated and *=p<0.05.